Dermatology NewsNemolizumab Benefits for Atopic Dermatitis Maintained in Long-Term Follow-Up StudyNovember 12, 2024Atopic DermatitisPediatrics
Dermatology NewsLichen Planus Responds to Treatment with Topical Ruxolitinib in Phase 2 StudyNovember 12, 2024Autoimmune DiseasesHair & Nails
Dermatology NewsStudy Finds No Increased MACE Risk for JAK Inhibitors in Patients With Atopic DermatitisNovember 12, 2024Atopic Dermatitis
Dermatology NewsTopical JAK Inhibitor Effective for Hand Eczema, Two Studies SuggestNovember 12, 2024Atopic Dermatitis
Dermatology NewsMany Patients With Cancer Visit EDs Before DiagnosisNovember 11, 2024Mixed TopicsMelanomaNonmelanoma Skin Cancer
Dermatology NewsPemphigus, Bullous Pemphigoid Risk Increased After COVID-19 InfectionNovember 11, 2024Autoimmune DiseasesInfectious DiseasesCOVID-19 Updates
Dermatology NewsRosacea: Ivermectin’s Benefits May Include Impact on Skin MicrobiomeNovember 11, 2024Rosacea
Dermatology NewsInfliximab vs Adalimumab: Which Is Best for Behçet Syndrome?November 8, 2024Medical Dermatology
Eating Disorder Risk Factors and the Impact of Obesity in Patients With PsoriasisNovember 8, 2024Psoriasis
Dermatology NewsPlasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With CancerNovember 8, 2024Mixed TopicsMelanomaNonmelanoma Skin Cancer
Dermatology NewsDigital Danger: How Cyberattacks Put Patients at RiskNovember 8, 2024Business of MedicinePractice Management
Disparities in Skin Cancer Outcomes in the Latine/Hispanic PopulationNovember 7, 2024Diversity in MedicineMelanomaNonmelanoma Skin Cancer
